All Outputs (2)

Expression of semaphorin-3A in the joint and role in osteoarthritis (2024)
Journal Article
Li, X., Martinez-Ramos, S., Heedge, F., Pitsillides, A., Bou-Gharios, G., Poulet, B., & Chenu, C. (2024). Expression of semaphorin-3A in the joint and role in osteoarthritis. Cell Biochemistry and Function, 42(3), https://doi.org/10.1002/cbf.4012

Osteoarthritis (OA) is characterised by the deterioration of cartilage in the joints and pain. We hypothesise that semaphorin-3A (sema-3A), a chemorepellent for sensory nerves, plays a role in joint degradation and pain. We used the mechanical joint... Read More about Expression of semaphorin-3A in the joint and role in osteoarthritis.

Stable Sulforaphane Targets the Early Stages of Osteoclast Formation to Engender a Lasting Functional Blockade of Osteoclastogenesis (2024)
Journal Article
Louka, P., Orriss, I. R., & Pitsillides, A. A. (2024). Stable Sulforaphane Targets the Early Stages of Osteoclast Formation to Engender a Lasting Functional Blockade of Osteoclastogenesis. Cells, 13(2), https://doi.org/10.3390/cells13020165

Sulforaphane, the native but unstable form of SFX-01, is an antioxidant that activates the NRF2 and inhibits the NF-KB pathways to achieve its actions. Resolving the mechanism(s) by which SFX-01 serves to control the various osteoclastogenic stages m... Read More about Stable Sulforaphane Targets the Early Stages of Osteoclast Formation to Engender a Lasting Functional Blockade of Osteoclastogenesis.